<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dtd-version="1.3" article-type="editorial">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2025.1771093</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Editorial</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: New trends in type 2 diabetes diagnosis and management in primary care, volume II</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Klisic</surname> <given-names>Aleksandra</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<uri xlink:href="https://loop.frontiersin.org/people/1046178"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Tzeng</surname> <given-names>I-Shiang</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x00026; editing</role>
<uri xlink:href="https://loop.frontiersin.org/people/791509"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Mercantepe</surname> <given-names>Filiz</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<uri xlink:href="https://loop.frontiersin.org/people/2270904"/>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Faculty of Medicine, University of Montenegro</institution>, <city>Podgorica</city>, <country country="me">Montenegro</country></aff>
<aff id="aff2"><label>2</label><institution>Center for Laboratory Diagnostics, Primary Health Care Center</institution>, <city>Podgorica</city>, <country country="me">Montenegro</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Statistics, School of Business, National Taipei University</institution>, <city>New Taipei</city>, <country country="tw">Taiwan</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Endocrinology and Metabolism, Faculty of Medicine, Recep Tayyip Erdogan University</institution>, <city>Rize</city>, <country>Turkey</country></aff>
<author-notes>
<corresp id="c001"><label>&#x0002A;</label>Correspondence: Aleksandra Klisic, <email xlink:href="mailto:aleksandranklisic@gmail.com">aleksandranklisic@gmail.com</email></corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-12">
<day>12</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>12</volume>
<elocation-id>1771093</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>12</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>12</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2026 Klisic, Tzeng and Mercantepe.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Klisic, Tzeng and Mercantepe</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-12">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>cardiovascular risk</kwd>
<kwd>insulin resistance</kwd>
<kwd>primary care</kwd>
<kwd>screening</kwd>
<kwd>type 2 diabetes</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="2"/>
<page-count count="3"/>
<word-count count="1696"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Family Medicine and Primary Care</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes notes-type="frontiers-research-topic">
<p><bold>Editorial on the Research Topic</bold> <ext-link xlink:href="https://www.frontiersin.org/research-topics/57655/new-trends-in-type-2-diabetes-diagnosis-and-management-in-primary-care-volume-ii/magazine" ext-link-type="uri">New trends in type 2 diabetes diagnosis and management in primary care, volume II</ext-link></p></notes>
</front>
<body>
<p>Type 2 diabetes mellitus (T2DM) continues to represent one of the most substantial and persistent global health challenges, with its burden extending far beyond glycemic control to encompass cardiovascular disease, microvascular complications, healthcare utilization, and socioeconomic consequences (<xref ref-type="bibr" rid="B1">1</xref>). As the prevalence of T2DM rises worldwide, primary care settings remain the cornerstone of early detection, risk stratification, long-term management, and patient-centered prevention strategies (<xref ref-type="bibr" rid="B2">2</xref>). In this context, primary care professionals are increasingly required to integrate evolving diagnostic tools, therapeutic innovations, and multidisciplinary approaches into everyday clinical practice.</p>
<p>Following the strong interest generated by the first volume of <italic>New Trends in Type 2 Diabetes Diagnosis and Management in Primary Care</italic>, the present Volume II was conceived to capture the rapid developments that have emerged in recent years. Since the publication of the initial Research Topic, the field has undergone significant transformation, driven by advances in predictive modeling, growing attention to real-world healthcare delivery, digital and artificial intelligence&#x02013;assisted tools, and a deeper understanding of behavioral, psychosocial, and system-level determinants of diabetes outcomes. Together, these changes underscore the need for updated, practice-oriented insights tailored specifically to the realities of primary care.</p>
<p>The articles included in this Research Topic collectively address several interconnected dimensions of contemporary diabetes care. The scope and thematic structure of this Research Topic are summarized in <xref ref-type="fig" rid="F1">Figure 1</xref>, which illustrates a primary care&#x02013;centered framework for contemporary T2DM management. A central theme across multiple contributions is the importance of early identification of dysglycemia and risk stratification. Predictive approaches that combine readily available clinical and biochemical variables demonstrate the potential to identify individuals at high risk for impaired fasting glucose and future diabetes, offering pragmatic tools that can be implemented in resource-constrained primary care environments &#x0201C;<italic>A study on predicting impaired fasting glucose risk in Chinese adults based on individual characteristics</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2025.1584626">Lin et al.</ext-link>). Such strategies align closely with the shift toward prevention-focused care and personalized risk communication.</p>
<fig position="float" id="F1">
<label>Figure 1</label>
<caption><p>A primary care-centered framework for contemporary diagnosis and management of type 2 diabetes.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-12-1771093-g0001.tif">
<alt-text content-type="machine-generated">Diagram illustrating a primary care-centered Type 2 diabetes management model. Central hexagon labeled &#x0201C;Primary Care-Centered Type 2 Diabetes Management&#x0201D; connects with six surrounding circles: &#x0201C;Early Detection &#x00026; Risk Prediction,&#x0201D; &#x0201C;Personalized &#x00026; Optimized Treatment,&#x0201D; &#x0201C;Patient Engagement &#x00026; Self-Management,&#x0201D; &#x0201C;Outcomes, Complications &#x00026; Health System Impact,&#x0201D; &#x0201C;Digital Health &#x00026; Innovative Care Models,&#x0201D; and &#x0201C;Outcome, Complications &#x00026; Health System Impact.&#x0201D; Each circle details specific strategies and components related to diabetes management. Arrows indicate the interconnections between these elements.</alt-text>
</graphic>
</fig>
<p>Another prominent focus of this volume relates to healthcare utilization, system-level outcomes, and economic implications of diabetes management. Analyses of inpatient expenditure and patterns of care provide valuable insight into the drivers of healthcare costs, highlighting the influence of comorbidities, disease complexity, and care pathways &#x0201C;<italic>In-patient expenditure between 2011 and 2021 for patients with type 2 diabetes mellitus: a hospital-based multicenter retrospective study in southwest China</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fpubh.2025.1559424">He et al.</ext-link>). In parallel, the examination of healthcare delivery during the COVID-19 pandemic offers a unique natural experiment, illustrating how reductions in structured chronic disease management programs may lead to compensatory increases in general practitioner visits and hospital-based care &#x0201C;<italic>Downsizing chronic disease management programs for type 2 diabetes patients during the COVID-19 pandemic: changes in healthcare utilization patterns</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2025.1490175">Rijpkema et al.</ext-link>). These findings reinforce the critical role of sustained, well-organized primary care programs in mitigating downstream healthcare burden.</p>
<p>Several contributions extend beyond biomedical outcomes to explore the human and behavioral dimensions of diabetes management, which are particularly salient in primary care. Studies addressing dietary adherence, self-care practices, and socioeconomic determinants reveal persistently high rates of non-adherence and identify structural barriers such as food insecurity, limited health literacy, and restricted access to healthcare services &#x0201C;<italic>Adherence to recommended diet among patients with diabetes mellitus type 2 on follow-up at Adama Hospital Medical College, Ethiopia</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2024.1484071">Abose et al.</ext-link>); &#x0201C;<italic>Adherence to diabetic self-care management and associated factors among type 2 diabetic patients in North Shewa Zone public hospitals in Amhara Region, Ethiopia</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcdhc.2025.1560907">Endale et al.</ext-link>). Importantly, these findings emphasize that effective diabetes management cannot be achieved through pharmacological strategies alone, but requires integrated approaches combining education, social support, and health system responsiveness. In this context, qualitative research focusing on interprofessional colla borative care highlights the practical challenges faced by newly trained healthcare professionals when translating interprofessional education into real-world diabetes management within primary care settings &#x0201C;<italic>A grounded theory research protocol on an attempt to practice interprofessional collaborative care by a primary care clinic health professional fresh graduate in diabetes care</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2023.1133948">Num et al.</ext-link>).</p>
<p>Innovation in care delivery is another defining feature of this Research Topic. Qualitative investigations into artificial intelligence&#x02013;assisted diabetic retinopathy screening offer valuable real-world perspectives from general practice staff, shedding light on feasibility, trust, and implementation challenges &#x0201C;<italic>Valuable insights into general practice staff&#x00027;s experiences and perspectives on AI-assisted diabetic retinopathy screening&#x02014;An interview study</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2025.1565532">Krogh et al.</ext-link>). These insights are essential as digital health tools increasingly transition from pilot projects to routine clinical use. Similarly, emerging approaches to insulin delivery, such as needle-free injection systems, address psychological insulin resistance and patient acceptance&#x02014;factors that often determine the success or failure of intensification strategies in everyday practice &#x0201C;<italic>Effect of needle-free injection on psychological insulin resistance and insulin dosage in patients with type 2 diabetes</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2024.1379830">Wang et al.</ext-link>).</p>
<p>The scope of this volume also encompasses acute and high-risk clinical scenarios that intersect with primary care decision-making. Studies examining prognostic biomarkers in diabetic ketoacidosis &#x0201C;<italic>Association between blood urea nitrogen to serum albumin ratio and in-hospital mortality in critical patients with diabetic ketoacidosis</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2024.1411891">Chen et al.</ext-link>), longitudinal changes in resting heart rate as predictors of adverse outcomes &#x0201C;<italic>Effects of temporal changes in resting heart rate on future diabetes-related outcomes</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2024.1385143">Gao et al.</ext-link>), and complex endocrine emergencies &#x0201C;<italic>Case report: management of a young male patient with diabetic ketoacidosis and thyroid storm</italic>&#x0201D; (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fendo.2024.1403893">Huang et al.</ext-link>) highlight the need for vigilance, timely referral, and interdisciplinary collaboration. Although such conditions may present in hospital settings, early recognition and appropriate triage frequently depend on primary care awareness and continuity of care.</p>
<p>Taken together, the contributions in this Research Topic underscore a central message: modern diabetes care in primary care settings is no longer defined solely by glycemic targets, but by a broader, more nuanced framework that integrates prediction, prevention, patient experience, system efficiency, and long-term outcomes. The diversity of methodologies represented&#x02014;ranging from large database analyses and cohort studies to qualitative research and clinical trials&#x02014;reflects the multifaceted nature of diabetes management and the necessity of addressing it from multiple angles.</p>
<p>As Topic Editor, we believe that this Research Topic provides timely and clinically relevant insights for primary care physicians, researchers, and policymakers alike. By bridging evidence-based innovations with real-world practice, <italic>New trends in type 2 diabetes diagnosis and management in primary care, volume II</italic> aims to support more effective, equitable, and patient-centered diabetes care. We hope that the perspectives presented here will stimulate further research, encourage interdisciplinary collaboration, and ultimately contribute to improved outcomes for individuals living with type 2 diabetes.</p>
<p><xref ref-type="fig" rid="F1">Figure 1</xref> illustrates a conceptual, primary care-centered model for contemporary type 2 diabetes management. Primary care is positioned at the core of diabetes care, integrating early detection and risk prediction, personalized and optimized treatment strategies, patient engagement and self-management, digital health innovations, and the monitoring of outcomes, complications, and healthcare system impact. The interconnected domains reflect the multifaceted approaches addressed in this Research Topic and highlight the central role of primary care in coordinating prevention, individualized care, real-world implementation, and long-term outcome optimization for individuals with type 2 diabetes.</p>
</body>
<back>
<sec sec-type="author-contributions" id="s1">
<title>Author contributions</title>
<p>AK: Conceptualization, Writing &#x02013; original draft, Writing &#x02013; review &#x00026; editing, Data curation. I-ST: Writing &#x02013; review &#x00026; editing. FM: Conceptualization, Data curation, Writing &#x02013; original draft.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s2">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec>
<sec sec-type="disclaimer" id="s3">
<title>Publisher&#x00027;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title> 
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klisic</surname> <given-names>A</given-names></name> <name><surname>Radoman Vujacic</surname> <given-names>I</given-names></name> <name><surname>Munjas</surname> <given-names>J</given-names></name> <name><surname>Ninic</surname> <given-names>A</given-names></name> <name><surname>Kotur-Stevuljevic</surname> <given-names>J</given-names></name></person-group>. <article-title>Micro-ribonucleic acid modulation with oxidative stress and inflammation in patients with type 2 diabetes mellitus - a review article</article-title>. <source>Arch Med Sci</source>. (<year>2022</year>)<volume>18</volume>:<fpage>870</fpage>&#x02013;<lpage>80</lpage>. doi: <pub-id pub-id-type="doi">10.5114/aoms/146796</pub-id><pub-id pub-id-type="pmid">35832702</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klisic</surname> <given-names>A</given-names></name> <name><surname>Tzeng</surname> <given-names>IS</given-names></name></person-group>. <article-title>Editorial: New trends in type 2 diabetes diagnosis and management in primary care</article-title>. <source>Front Med</source>. (<year>2023</year>)10:1243319. doi: <pub-id pub-id-type="doi">10.3389/fmed.2023.1243319</pub-id><pub-id pub-id-type="pmid">37484848</pub-id></mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0001">
<p>Edited and reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1112525/overview">Arch Mainous</ext-link>, University of Florida, United States</p>
</fn>
</fn-group>
</back>
</article>